pfizerbiontech covid 19 vaccine
-
FDA OKs Moderna and Johnson & Johnson Boosters in the U.S., And for People to Mix and Match
On Wednesday night, the U.S. Food and Drug Administration officially authorised the use of boosters for eligible people vaccinated against covid-19 with either the Moderna and Johnson & Johnson vaccine. They’ve also given their blessing for people to mix and match different types of vaccines for their booster — a likely welcome decision for the…
-
FDA Authorizes Pfizer Boosters for People 65 and Older and Those at High Risk for Severe Covid-19
After weeks of wondering who will get covid-19 booster shots and when — and receiving confusing advice from a variety of public officials — the Food and Drug Administration has made a decision.
-
100,000 Hospitalised With Covid-19 as U.S. Somehow Faces New Pandemic Surge
As of Wednesday afternoon, according to at least one tracker, more than 100,000 Americans are hospitalised with covid-19. The “milestone” is yet another sign that the country is again being battered by the pandemic, despite the availability of several effective vaccines. Data continues to indicate that most of those hospitalised are likely to be unvaccinated.
-
Third Moderna Shot Boosts Transplant Recipients’ Immune Response, Canadian Trial Finds
A randomised clinical trial in Canada has found that three doses of the Moderna vaccine are effective at boosting organ transplant recipients’ immune response to the coronavirus, suggesting they would be better protected from illness and infection. The finding could result in the expedited approval of third jabs for this vulnerable population.